Private Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SiriusXM
SIRI
|
+$4.43M |
| 2 |
Madison Square Garden
MSGS
|
+$4.24M |
| 3 |
STML
Stemline Therapeutics, Inc.
STML
|
+$3.2M |
| 4 |
CVR Energy
CVI
|
+$2.42M |
| 5 |
Allstate
ALL
|
+$2.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGMO
SANGAMO THERAPEUTICS INC
SGMO
|
+$14.7M |
| 2 |
Visa
V
|
+$4.9M |
| 3 |
Citigroup
C
|
+$4.48M |
| 4 |
Biogen
BIIB
|
+$4.1M |
| 5 |
Arrowhead Research
ARWR
|
+$4.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 18.46% |
| 2 | Communication Services | 18.44% |
| 3 | Healthcare | 15.65% |
| 4 | Industrials | 11.15% |
| 5 | Consumer Discretionary | 9.87% |
Similar funds
Private Capital Advisors's Q1 2014 Portfolio in Review
As of Q1 2014, Private Capital Advisors held 117 positions worth $263M, down 10% from $292M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Private Capital Advisors withdrew a net $29M in Q1 2014, closing 15 positions and reducing 44 holdings. Its most notable exit was SANGAMO THERAPEUTICS INC, an estimated $14.7M position sold in full.
By sector, the portfolio is most concentrated in Energy at 18% of assets, up from 17% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Private Capital Advisors opened a new position in SiriusXM worth $4.01M.
- Private Capital Advisors's largest Q1 2014 buy was SiriusXM: 125,230 shares worth $4.01M.
- Private Capital Advisors added most to Liberty Global Class C in Q1 2014, an estimated $2.05M increase.
- Private Capital Advisors's biggest Q1 2014 reduction was Apple, cutting an estimated $2.93M.
- Private Capital Advisors fully exited SANGAMO THERAPEUTICS INC in Q1 2014, selling an estimated $14.7M.
- Private Capital Advisors's ten largest holdings make up 30% of its $263M portfolio in Q1 2014.
- Private Capital Advisors opened 10 new positions and closed 15 in Q1 2014.
- Private Capital Advisors's portfolio value fell 10% quarter-over-quarter to $263M.
Based on Private Capital Advisors's 13F filing for Q1 2014, filed 23 Apr 2014.